Nov 25, 2024 3:19:54 PM       by Team ABclonal

Gasdermins – the "Gatekeepers" of Pyroptosis

It is evident that the gasdermin family is central to pyroptosis. This is because the gasdermin family members are the executioners of pyroptosis, and their pore-forming function is a necessary condition for pyroptosis to occur. This family generally includes a cytotoxic N-terminal domain and a C-terminal inhibitory domain. After cleavage, the N-terminal domain is released and can assemble into pores in the membrane. Gasdermin pores disrupt the integrity of the cell membrane, leading to inflammatory cell death, with cell contents, including inflammatory cytokines, being released into the extracellular space.

 


Oct 25, 2024 12:10:07 PM       by Team ABclonal

Pyroptosis: The Fiery Path of Cell Death


In the 1980s and 1990s, scientists discovered that macrophages exposed to bacterial toxins or infections underwent a unique form of cell death that required the activation of caspase-1. For years, this process was mistakenly classified as apoptosis, a non-inflammatory and orderly form of cell death. However, unlike apoptosis, this newly observed cell death was marked by swelling, rupture, and the release of inflammatory signals, indicating a far more chaotic and immune-activating process. It wasn’t until 2001 that Cookson BT and Brennan MA officially named this inflammatory form of cell death “pyroptosis”. [2] Since then, research has revealed that pyroptosis plays a key role in immune defense by promoting inflammation in response to infections. The discovery of gasdermin D (GSDMD), a protein that forms pores in the cell membrane, further clarified the mechanism of pyroptosis. Today, it’s understood that pyroptosis occurs in various cell types and is critical in both fighting infections and contributing to inflammatory diseases when dysregulated.

 

Sep 1, 2024 12:00:00 PM       by Kin Leung

Get With the Program(med Cell Death)!

Although the phenomenon of cell death had been known for centuries, even briefly described in the 19th century, the explosion of research and technology in the latter half of the 20th century led to greater and more nuanced discoveries that have provided insights into many physiological processes including tissue development, maintenance, metabolism, and disease states including cancer. The many accomplishments in programmed cell death research have improved our understanding and development of targeted therapeutics, and some of these milestones were recognized by Nobel Prizes for apoptosis and autophagy. As scientists continue to elucidate new cell death pathways and their interplay with other pathways, let's take a look at what we know so far and what new findings have come out.


Jun 30, 2022 12:00:00 PM       by Kin Leung

Another Way to Kill Bad Cells: Recent Work in Pyroptosis

Once upon a time when I was a fledgling science nerd in high school, I started learning about the process of apoptosis, which remains to this day the most studied form of cell death in various functions including organismal development and defense against cancer. As an immunologist-in-training, I also learned about the classical complement pathway that the immune system uses to destroy infected cells, and also necrotic cell death or necroptosis (which is full of really gross pictures if you dare to Google it). Of course, I learned about autophagy in graduate school and really appreciate its utility in normal physiology and disease, while very recently I read about ferroptosis as yet another programmed cell death (PCD) pathway. Right around when the Nobel Prize was awarded to recognize the elucidation of PCD, pyroptosis came about as a novel PCD pathway that is continuing to gain steam in its clinical relevance. It seems logical for cells and organisms to have redundant systems in place to clear away damaged and malignant cells before a health crisis can emerge if the cell evades the primary route of apoptosis.